Praxis Precision Medicines, Inc. (PRAX) Cash Flow Statement
Praxis Precision Medicines, Inc. (PRAX) generated -$305.1M of operating cash flow over the twelve months to 2026-06-30, spent $1.1M on capital expenditure and had free cash flow of -$306.2M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PRAXPraxis Precision Medicines, Inc.Follow PRAX — free
—
Price chart with a free account
- Market cap
- 7.1B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|
| Operating cash flow | -0.11 | -0.13 | -0.25 | -0.31 | |
| Capital expenditure | 0.00 | 0.00 | 0.00 | -0.00 | |
| Free cash flow | -0.11 | -0.13 | -0.25 | -0.31 | |
| Stock-based compensation | 0.02 | 0.04 | 0.03 | — |
USD billions · SEC XBRL
Praxis Precision Medicines, Inc. — questions
- What is Praxis Precision Medicines, Inc.'s operating cash flow?
- -$305.1M over the twelve months to 2026-06-30.
- How much does Praxis Precision Medicines, Inc. spend on capital expenditure?
- $1.1M over the twelve months to 2026-06-30.
- What is Praxis Precision Medicines, Inc.'s free cash flow?
- -$306.2M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Praxis Precision Medicines, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.